Drug recall
Tetracycline HCl Capsules USP, 250 mg, Rx only, packaged in a) 100-count capsules per carton (NDC…
FDA recall event 61189 · Class II · Teva Pharmaceuticals USA, Inc.
Key facts
| Event ID | 61189 |
|---|---|
| Recall numbers | D-1330-2012, D-1331-2012 |
| Recalling firm | Teva Pharmaceuticals USA, Inc. |
| Product type | Drugs |
| Products | Tetracycline HCl Capsules USP, 250 mg, Rx only, packaged in a) 100-count capsules per carton (NDC 0172-2416-10), UPC 3 0172-2416-10 1, packaged in 10 cards of 10 x 1-count capsules per blister (NDC…, Tetracycline HCl Capsules USP, 500 mg, Rx only, packaged in a) 100-count capsules per carton (NDC 0172-2407-10), UPC 3 0172-2407-10 1, packaged in 10 cards of 10 x 1-count capsules per blister (NDC… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Presence of Foreign Substance(s): There is a potential for foreign particulate matter in the API. |
| Initiation date | Feb 9, 2012 |
| Termination date | Apr 10, 2013 |
| City | Sellersville |
| State | PA |
| Country | United States |
| FEI number | 2517175 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports